© 2000 American Heart Association, Inc.
Cellular Biology |
Release of Active Tissue Factor by Human Arterial Smooth Muscle Cells
From the Cardiovascular Institute (A.D.S., M.R., J.T.F., E.A.F., M.B.T.), Division of Thrombosis Research (P.L.A.G., V.B., Y.N.), Division of Pulmonary Medicine (L.M.S.), Department of Medicine (A.D.S., B.S., M.R., P.L.A.G., V.B., J.T.F., E.A.F., L.M.S., Y.N., M.B.T.), and Department of Pathology (J.T.F.), Mount Sinai School of Medicine, New York, NY.
Correspondence to Mark B. Taubman, Mount Sinai School of Medicine, Box 1269, One Gustave L. Levy Place, New York, NY 10029. E-mail mark.taubman{at}mssm.edu
Abstract—Tissue factor (TF), the
initiator of coagulation, is thought to function predominantly at the
cell surface. Recent data have suggested that active TF is present
extracellularly in atherosclerotic plaques, the arterial
wall, and the blood. This study was conducted to determine whether
smooth muscle cells (SMCs), a major source of arterial TF,
could generate extracellular TF. Active TF accumulated in the medium of
cultured human SMCs, representing 
10% of that measured
in the underlying cells at 24 hours. Platelet-derived growth
factor, phorbol ester, and tumor necrosis factor-
caused 3-fold
increases in TF activity in the medium. Release of TF into the medium
was dependent on the presence of the TF transmembrane domain but not
the cytoplasmic domain. Antibodies to TF precipitated most of the
activity from the culture medium, whereas antibodies to the
ß1-integrin subunit precipitated 33% of the activity.
Treatment with detergent or
phosphatidylserine:phosphatidylcholine did not
increase activity, suggesting that all TF released by SMCs was in the
appropriate lipid milieu and not encrypted. Western blotting showed
that the medium contained full-length TF protein. Fluorescent
cytometry showed that extracellular TF was present largely in
particles 
200 nm, which had a density of 1.10 g/mL. We hypothesize
that active extracellular TF found in the injured arterial
wall and atherosclerotic plaques derives, in part, from SMC
microparticles. (Circ Res. 2000;87:126-132.)
Key Words: smooth muscle • tissue factor • thrombosis • microparticles
This article has been cited by other articles:
 |
|
 |
|
  G. G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T. F. Luscher, and F. C. Tanner Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents Eur. Heart J., January 2, 2010; 31(2): 236 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Atkinson Age-related medial elastocalcinosis in arteries: mechanisms, animal models, and physiological consequences J Appl Physiol, November 1, 2008; 105(5): 1643 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mackman, R. E. Tilley, and N. S. Key Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis Arterioscler Thromb Vasc Biol, August 1, 2007; 27(8): 1687 - 1693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Morel, F. Toti, B. Hugel, B. Bakouboula, L. Camoin-Jau, F. Dignat-George, and J.-M. Freyssinet Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? Arterioscler Thromb Vasc Biol, December 1, 2006; 26(12): 2594 - 2604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Potteaux, C. Combadiere, B. Esposito, C. Lecureuil, H. Ait-Oufella, R. Merval, P. Ardouin, A. Tedgui, and Z. Mallat Role of Bone Marrow-Derived CC-Chemokine Receptor 5 in the Development of Atherosclerosis of Low-Density Lipoprotein Receptor Knockout Mice Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1858 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Stampfuss, P. Censarek, J. W. Fischer, K. Schror, and A.-A. Weber Rapid Release of Active Tissue Factor From Human Arterial Smooth Muscle Cells Under Flow Conditions Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): e34 - e37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Suzuki, Z.-G. Jin, D. F. Meoli, T. Matoba, and B. C. Berk Cyclophilin A Is Secreted by a Vesicular Pathway in Vascular Smooth Muscle Cells Circ. Res., March 31, 2006; 98(6): 811 - 817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Steffel, T. F. Luscher, and F. C. Tanner Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications Circulation, February 7, 2006; 113(5): 722 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Cirillo, P. Golino, P. Calabro, G. Cali, M. Ragni, S. De Rosa, G. Cimmino, M. Pacileo, R. De Palma, L. Forte, et al. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation Cardiovasc Res, October 1, 2005; 68(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steffel, R. A. Latini, A. Akhmedov, D. Zimmermann, P. Zimmerling, T. F. Luscher, and F. C. Tanner Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design Circulation, September 27, 2005; 112(13): 2002 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steffel, A. Akhmedov, H. Greutert, T. F. Luscher, and F. C. Tanner Histamine Induces Tissue Factor Expression: Implications for Acute Coronary Syndromes Circulation, July 19, 2005; 112(3): 341 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Boulanger and A. Tedgui Dying for attention: Microparticles and angiogenesis Cardiovasc Res, July 1, 2005; 67(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
B. Szotowski, S. Antoniak, W. Poller, H.-P. Schultheiss, and U. Rauch Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines Circ. Res., June 24, 2005; 96(12): 1233 - 1239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Steffel, M. Hermann, H. Greutert, S. Gay, T. F. Luscher, F. Ruschitzka, and F. C. Tanner Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH2 Kinase Phosphorylation Circulation, April 5, 2005; 111(13): 1685 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Martinez, A. Tesse, F. Zobairi, and R. Andriantsitohaina Shed membrane microparticles from circulating and vascular cells in regulating vascular function Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1004 - H1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ravassa, A. Bennaghmouch, H. Kenis, T. Lindhout, T. Hackeng, J. Narula, L. Hofstra, and C. Reutelingsperger Annexin A5 Down-regulates Surface Expression of Tissue Factor: A NOVEL MECHANISM OF REGULATING THE MEMBRANE RECEPTOR REPERTOIR J. Biol. Chem., February 18, 2005; 280(7): 6028 - 6035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Rong, D. E. Post, R. O. Pieper, D. L. Durden, E. G. Van Meir, and D. J. Brat PTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma Cancer Res., February 15, 2005; 65(4): 1406 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Day, J. L. Reeve, B. Pedersen, D. M Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman, and W. P. Fay Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall Blood, January 1, 2005; 105(1): 192 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chou, N. Mackman, G. Merrill-Skoloff, B. Pedersen, B. C. Furie, and B. Furie Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation Blood, November 15, 2004; 104(10): 3190 - 3197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Llorente-Cortes, M. Otero-Vinas, S. Camino-Lopez, O. Llampayas, and L. Badimon Aggregated Low-Density Lipoprotein Uptake Induces Membrane Tissue Factor Procoagulant Activity and Microparticle Release in Human Vascular Smooth Muscle Cells Circulation, July 27, 2004; 110(4): 452 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Aras, A. Shet, R. R. Bach, J. L. Hysjulien, A. Slungaard, R. P. Hebbel, G. Escolar, B. Jilma, and N. S. Key Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia Blood, June 15, 2004; 103(12): 4545 - 4553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland Microparticles in cardiovascular diseases Cardiovasc Res, August 1, 2003; 59(2): 277 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Falati, Q. Liu, P. Gross, G. Merrill-Skoloff, J. Chou, E. Vandendries, A. Celi, K. Croce, B. C. Furie, and B. Furie Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin J. Exp. Med., June 2, 2003; 197(11): 1585 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Balasubramanian, E. Grabowski, A. Bini, and Y. Nemerson Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions Blood, September 26, 2002; 100(8): 2787 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mallat and A. Tedgui Current Perspective on the Role of Apoptosis in Atherothrombotic Disease Circ. Res., May 25, 2001; 88(10): 998 - 1003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tedgui and Z. Mallat Smooth Muscle Cells : Another Source of Tissue Factor-Containing Microparticles in Atherothrombosis? Circ. Res., July 21, 2000; 87(2): 81 - 82. [Full Text] [PDF]
|
|
|
|
|
|
O. Herkert, I. Diebold, R. P. Brandes, J. Hess, R. Busse, and A. Gorlach NADPH Oxidase Mediates Tissue Factor-Dependent Surface Procoagulant Activity by Thrombin in Human Vascular Smooth Muscle Cells Circulation, April 30, 2002; 105(17): 2030 - 2036. [Abstract] [Full Text] [PDF]
|
|